Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart device under watch: new study tracks Real-World safety

NCT ID NCT05788432

Disease control Sponsor: Fundación EPIC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This study monitors the safety and performance of a medical device called Sequent Please Neo, used to treat blocked heart arteries. About 2,028 people receiving the device as part of their routine care will be followed. Researchers will track major heart problems like heart attacks or the need for repeat procedures to confirm the device works well in everyday practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

2,040 people

The number who actually took part.

Started

Mar 2023

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients treated with Sequent Please Neo according to routine hospital practice and following instructions for use.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients treated with Sequent please neo according to routine hospital practice and following instruction for use. * Informed Consent Signed. Exclusion Criteria: * Patient life expectancy less than 12 months. * Contraindication for antiplatelet therapy. * Not meet inclusion criteria.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery disease Ischemic heart disease

Contacts and locations

Locations

  • Hospital Clinic de Barcelona

    Barcelona, 08036, Spain

  • Hospital Clinico Universitario de Salamanca

    Salamanca, 37007, Spain

  • Hospital General Universitari de Castelló

    Castelló, 12004, Spain

  • Hospital General Universitario de Alicante Dr.Balmis

    Alicante, 03010, Spain

  • Hospital General Universitario de Elche

    Elche, 03203, Spain

  • Hospital General Universitario de Toledo

    Toledo, 45007, Spain

  • Hospital Regional Universitario de Malaga

    Málaga, 29010, Spain

  • Hospital Universitari Dr. Josep Trueta

    Girona, 17007, Spain

  • Hospital Universitari Germans Trias I Pujol

    Badalona, 08916, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, 28041, Spain

  • Hospital Universitario Juan Ramon Jimenez

    Huelva, 21005, Spain

  • Hospital Universitario Lucus Agusti

    Lugo, 27003, Spain

  • Hospital Universitario Puerta Del Mar

    Cadiz, 11009, Spain

  • Hospital Universitario Puerto Real

    Puerto Real, 11510, Spain

  • Hospital Universitario San Pedro de Alcantara

    Cáceres, 10003, Spain

  • Hospital Universitario Virgen Del Rocio

    Seville, 41013, Spain

  • Hospital Universitario Virgen de La Victoria

    Málaga, 29010, Spain

  • Hospital Universitario de Araba

    Alava, 01009, Spain

  • Hospital Universitario de Badajoz

    Badajoz, 06080, Spain

  • Hospital Universitario de Cabueñes

    Gijón, 33394, Spain

  • Hospital Universitario de Ciudad Real

    Ciudad Real, 13005, Spain

  • Hospital Universitario de Cruces

    Barakaldo, 48903, Spain

  • Hospital Universitario de Jaen

    Jaén, 23007, Spain

  • Hospital Universitario de La Princesa

    Madrid, 28006, Spain

  • Hospital Universitario de Leon

    León, 240801, Spain

  • Hospital de La Santa Creu Y Sant Pau

    Barcelona, 08025, Spain

  • Hospital de Mérida

    Mérida, 06800, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.